GeoVax Labs (GOVX) had the highest return between 2010 and 2019 by a US stock in the Biotechnology Industry, returning 23,672,273.7%.

ASSET	YEARS	% RETURN
GeoVax Labs (GOVX)	2010-2019	23,672,273.68%
AquaBounty Technologies (AQB)	2010-2019	602,677.78%
Processa Pharmaceuticals (PCSA)	2010-2019	428,471.43%
Immatics (IMTX)	2010-2019	207,900%
Avita Medical (RCEL)	2010-2019	22,868.2%
GT Biopharma (GTBP)	2010-2019	18,260%
Aurinia Pharmaceuticals (AUPH)	2010-2019	12,329.45%
Neurocrine Biosciences (NBIX)	2010-2019	3,780.51%
ACADIA Pharmaceuticals (ACAD)	2010-2019	3,140.91%
EXACT Sciences (EXAS)	2010-2019	2,542.29%
Travere Therapeutics (TVTX)	2010-2019	1,477.78%
Regeneron Pharmaceuticals (REGN)	2010-2019	1,449.01%
Evotec SE ADR (EVO)	2010-2019	1,426.49%
Amarin (AMRN)	2010-2019	1,399.3%
Sarepta Therapeutics (SRPT)	2010-2019	1,353.15%
Galapagos NV ADR (GLPG)	2010-2019	1,312.19%
Genmab A-S (GMAB)	2010-2019	1,237.13%
Arrowhead Pharmaceuticals (ARWR)	2010-2019	1,096.79%
MiMedx (MDXG)	2010-2019	938.36%
Incyte (INCY)	2010-2019	847.07%
argenx NV ADR (ARGX)	2010-2019	796.76%
Ligand Pharmaceuticals (LGND)	2010-2019	765.38%
Kodiak Sciences (KOD)	2010-2019	619.5%
Anika Therapeutics (ANIK)	2010-2019	576.89%
InMed Pharmaceuticals (INM)	2010-2019	566.67%